Johnson & Johnson’s (JNJ) Neutral Rating Reaffirmed at Guggenheim
Guggenheim reiterated their neutral rating on shares of Johnson & Johnson (NYSE:JNJ – Free Report) in a research note issued to investors on Monday morning,Benzinga reports. JNJ has been the topic of a number of other reports. Leerink Partners dropped their target price on Johnson & Johnson from $182.00 to $169.00 and set an “outperform” […]
Guggenheim reiterated their neutral rating on shares of Johnson & Johnson (NYSE:JNJ – Free Report) in a research note issued to investors on Monday morning,Benzinga reports. JNJ has been the topic of a number of other reports. Leerink Partners dropped their target price on Johnson & Johnson from $182.00 to $169.00 and set an “outperform” […]
